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Summary Using two monoclonal antibodies directed against placental alkaline phosphatase (H17E2 and
D20L) the immunohistological staining of testicular germ cell tumours was compared with that of a wide
range of normal and malignant tissues. All seminomas and malignant teratomas tested gave strong positive
labelling with H17E2 but were either negative or only patchily positive with D20L. Neither antibody gave any
positive reaction on the normal tissues tested. All other malignancies were negative with both antibodies apart
from two cases of ovarian and one case of endometrical cancer (strongly stained by H17E2) and three cases
of colonic carcinoma (weakly and patchily stained by both H17E2 and D20L). This indicates that germ cell
neoplasms generally express a form ofplacental alkaline phosphatase recognised by antibody H17E2.
It has long been recognised that the placenta
produces a form of alkaline phosphatase which can
be distinguished from the intestinal and liver
isozymes immunologically and by its heat stability
and susceptibility to various noncompetitive
inhibitors. Placental alkaline phosphatase is a cell
surface glycoprotein consisting of two subunits
both of approximately 67,000 daltons in molecular
weight (Budger & Sussman, 1976). It is known to
be highly polymorphic with more allelic forms than
any other human enzyme studied (Harris, 1982).
The ectopic appearance of placental alkaline
phosphatase has been reported using polyclonal
antisera in a wide range of neoplasms including
testis, ovary, lung, stomach and pancreas (Fishman
et al., 1976, 1968; Stolbach et al., 1969; Nathanson
& Fishman, 1971). It has also been reported to be
present in small amounts in normal cervix, lung
and a placental like form in the testis (Goldstein et
al., 1982; Chang et al., 1980). However, polyclonal
antisera to placental alkaline phosphatase cannot
clearly distinguish between its various forms and
may cross react with other alkaline phosphatase
isoenzymes, particularly the intestinal form. The
availability of monoclonal antibodies to placental
alkaline phosphatase makes it possible to analyse
the distribution of the enzyme with much greater
precision.
In the present paper we describe an
immunohistological study based on the use of two
monoclonal anti-placental alkaline phosphatase
antibodies and discuss the potential value of one of
these antibodies in the clinical management of germ
cell tumours.
Materials and methods
Histological specimens
Surgical biopsies were immediately frozen in liquid
nitrogen and stored until required. Cryostat
sections (5gm thickness) were collected on
gelatinised glass slides, air dried, fixed in acetone
for Omin and stained with an immunoperoxidase
technique.
Monoclonal antibodies
(a) D20L. This antibody was raised by J. Arklie
in the conventional fashion (Kohler & Milstein,
1975) against the colon carcinoma cell line LoVo
(Stragaard et al., 1980) which expresses placental
alkaline phosphatase. It was found to precipitate
placental alkaline phosphatase using extracts of
placenta and did not cross react with other non-
placental forms of alkaline phosphatase.
(b) H17E2. This antibody was raised by P.
Travers against purified plasma membranes of
normal term placenta. The antibody precipitates
placental alkaline phosphatase activity and a single
band of 67,000 daltons consistent with the
molecular weight ascribed to placental alkaline
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phosphatase (Travers & Bodmer, in preparation).
H17E2 also reacts with the leucine inhibitable form
of alkaline phosphatase found at low levels in the
normal testis and which is immunologically cross
reactive with the placental enzyme (Harris, 1982). It
did not cross react with other non-placental forms
of alkaline phosphatase.
(c) 11-4.1. This antibody is directed against the
mouse H-2Kk antigen (equivalent to human HLA)
and does not cross react with any human tissues
(Oi et al., 1979). This was used as a negative
control.
Immunoperoxidase reaction
The cryostat sections were incubated with one of
the monoclonal anti-placental alkaline phosphatase
antibodies (as neat tissue culture supernatant
(10pgml-1) followed by peroxidase conjugated
rabbit anti-mouse immunoglobulin (Dako
Immunoglobulins a/s). The peroxidase reaction was
developed using diaminobenzidine and hydrogen
peroxide. Sections were then counterstained with
haematoxylin and mounted for microscopical
examination.
Results
Normal tissues
Both monoclonal anti-placental alkaline
phosphatase antibodies gave strong
immunohistochemical reactions with human
placental syncytiotrophoblast (Figure 1). A range of
normal human tissues was tested using the same
immunoperoxidase techniques (Table I) but neither
Table I Immunohistochemical staining of human tissues
with monoclonal anti-placental alkaline phosphatase
antibodies
Normal tissues Number ofsamples H17E2 D20L
Breast 4 Negative Negative
Brain 1 Negative Negative
Skin 4 Negative Negative
Kidney 4 Negative Negative
Tonsil 3 Negative Negative
Stomach 1 Negative Negative
Colon 5 Negative Negative
Liver 1 Negative Negative
Oesophagus 1 Negative Negative
Cervix 2 Negative Negative
Lung 4 Negative Negative
Testis 4 Negative Negative
Ovary 2 Negative Negative
Uterus 1 Negative Negative
Placenta 5 Positive Positive
antibody gave any reactivity. These normal tissues
included biopsies of human testes which were
clearly unreactive (see Figure 4) and thus
contrasted with the reactivity of testicular tumours.
Malignant tumours
A wide range of biopsies from malignant tumours
(Table II) was examined with both antibodies.
Sixteen testicular tumours including seminomas and
malignant teratomas (detailed in Table II) all gave
positive reactions with H17E2 (Figures 2 and 3).
D20L showed a more restricted staining pattern
labelling only a small minority of cells in three
cases of seminoma.
All the other tumours examined (Table II) were
negative with both antibodies apart from one case
of papillary serous adenocarcinoma of the ovary, a
secondary poorly differentiated carcinoma of the
ovary and a poorly differentiated carcinoma of the
uterus (all strongly positive with H17E2) and three
cases of colonic carcinoma (weakly and patchily
stained with both antibodies).
Negative control antibody 11-4.1 produced a
negative reaction against all tested tissues.
Discussion
This study has identified a monoclonal antibody
H17E2 that reacts strongly with germ cell tumours
of the testis and some carcinomas of the female
genital tract. No normal tissues showed any
reactivity apart from placental syncytiotrophoblast
against which the antibody was raised.
Previous studies using polyclonal antisera have
provided evidence for the presence of placental
alkaline phosphatase in a wide range of human
neoplasms, e.g. seminoma of testis and tumours of
breast, ovary, lung, stomach and pancreas
(Fishman et al., 1968; Stolbach et al., 1979;
Nathanson & Fishman, 1971; Uchida et al., 1981;
Wada et al., 1979) as well as in some normal tissues
such as cervix, lung and testes (Goldstein et al.,
1982; Chang et al., 1980). It is known that placental
alkaline phosphatase is a highly complex enzyme
(Harris, 1982) which has been demonstrated in this
study by the different patterns of staining of the
two separate monoclonal antibodies directed
against placental alkaline phosphatase. This study
indicates that there is a particular epitope carried
by the enzyme which is present in high
concentration on normal human placental
syncytiotrophoblast, testicular germ cell tumours
and some tumours of the female genital tract. In
addition it would appear that the antigenic forms
recognised by both antibodies are present focally
and at much lower concentrations in some_,L - p %*
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Figure 1 Immunoperoxidase staining of term placenta
using monoclonal antibody H17E2. Note strongly
positive reaction with the membrane of
syncytiotrophoblast.
Figure 3 Immunoperoxidase staining of malignant
teratoma (undifferentiated) of testis with monoclonal
antibody H17E2. Note strongly positive reaction.
Figure 2 Immunoperoxidase staining of seminoma of
testis with monoclonal antibody H17E2. Note strongly
positive reaction.
Figure 4 Negative Immunoperoxidase staining of
normal testis with antibody H17E2.
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Table II Immunohistological reactions of testicular tumours and other neoplastic
tissues with monoclonal anti-placental alkaline phosphatase antibodies
No. of
Testicular tumours cases H17E2 D20L
Seminoma (Figure 2)
Malignant teratoma:
(a) Trophoblastic
(b) Intermediate
(c) Undifferentiated (Figure 3)
Mixed tumours:
(a) Malignant teratoma
undifferentiated and
seminoma
(b) Malignant teratoma
intermediate and seminoma
Carcinomas:
Squamous (skin)
Squamous (lung)
Basal cell (skin)
Malignant melanoma
Breast (ductal)
Kidney
Bladder
Colon
Prostrate
Thyroid
Carcinoid
Ovary
Uterus
Other neoplasms:
Neuroblastoma
Ewing's sarcoma
Wilm's tumour
Leiomyosarcoma
7
3
2
2
3
3
4
1
6
3
1
5
2
3
3
1
2
2
1
Strongly positive
Strongly positive
Strongly positive
Strongly positive
Strongly positive
Strongly positive
Negative
Negative
Negative
Negative
Negative
Negative
Negative
3 cases weak and
patchy positivity
2 cases negative
Negative
Negative
Negative
2 cases positive
Strongly positive
Negative
Negative
Negative
Negative
4 cases negative
3 cases small
minority ofcells
positive
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
as H17E2
Negative
Negative
Negative
Negative
Patchy positivity
Negative
Negative
Negative
Negative
carcinomas of the colon. This is not surprising since
one of the antibodies (D20L) was raised against a
colonic carcinoma cell line. Two out of 6 colon
carcinoma cell lines tested were positive with both
antibodies while of 5 breast carcinoma lines 1 was
positive (Travers & Bodmer, in preparation). It is
interesting that antibody D20L showed a narrower
distribution reacting only with some seminomas. It
seems likely therefore, that the alkaline phosphatase
found in germ cell tumours is the testis specific
form of the enzyme rather than the placental form.
This enzyme is expressed at low levels in the
normal testis (Harris, 1982) presumably below the
threshold of detectability by this study, but appears
in these tumours at elevated levels. In the colon and
uterine tumours, since D20L also shows reactivity,
it is likely that there is a true ectopic expression of
the placental isozyme.
For clinical use antibody H17E2 might be a
useful adjunct in the histopathological diagnosis of
testicular germ cell tumours providing that the
patchy weak reactivity with several of the cases of
colonic carcinoma is borne in mind. It could also
be incorporated in a radioimmunoassay (RIA) or
an enzyme linked immunoabsorbent assay (ELISA)
for monitoring the status of patients with germ cell
tumours as previously described by others using
both polyclonal antisera and monoclonal antibodies
(Lange, 1982; Millan et al., 1982; McLaughlin et
al., 1982).
However, the potential importance of H17E2 is
that in view of its specificity for placental alkaline
phosphatase and the apparent absence of reactivity
with normal tissues other than placenta, it could be
used in vivo for tumour localisation studies.
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(Epenetos et al., 1982; Farrands et al., 1982; Berche
et al., 1982) using other tumour-associated
monoclonal antibodies have shown promising
results with this approach as a means of localising
accurately the site and extent of tumours in
individual patients. Furthermore, its apparent lack
of reactivity with normal tissues renders it
potentially useful as a therapeutic agent in the
treatment of testicular germ cell tumours.
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